Show 10 5 10 15 20 50 100 250 Sort by year (new to old) Actions Download search results Subscribe to news feed Your filters: cql: keyword exact "parp inhibitors" Add to list Journal Article A1 Efficacy and safety of olaparib according to age in BRCA1/2-mutated patients with recurrent platinum-sensitive ovarian cancer : analysis of the phase III SOLO2/ENGOT-Ov21 study F. Trillsch, S. Mahner, B. Ataseven, R. Asher, N. Aryal, C. Dubot, A. Clamp, R. Penson, A. Oza, A. Amit, et al. (2022) GYNECOLOGIC ONCOLOGY. 165(1). p.40-48 Add to list Journal Article A1 Mutation analysis of RAD51D in non-BRCA1/2 ovarian and breast cancer families DJ Osher, Kim De Leeneer (UGent) , G Michils, N Hamel, E Tomiak, Bruce Poppe (UGent) , K Leunen, E Legius, A Shuen, E Smith, et al. (2012) BRITISH JOURNAL OF CANCER. 106(8). p.1460-1463 Add to list Journal Article A1 PARP inhibitors in oncology: a new synthetic lethal approach to cancer therapy VIBEKE KRUSE (UGent) , Sylvie Rottey (UGent) , Ole De Backer (UGent) , Simon Van Belle (UGent) , Veronique Cocquyt (UGent) and Hannelore Denys (UGent) (2011) ACTA CLINICA BELGICA. 66(1). p.2-9 Add to list Journal Article A2 PARP-inhibitors in breast and ovarian cancer VIBEKE KRUSE (UGent) , Veronique Cocquyt (UGent) , Rudy Van den Broecke (UGent) , Geert Braems (UGent) and Hannelore Denys (UGent) (2011) BELGIAN JOURNAL OF MEDICAL ONCOLOGY. 5(2). p.62-69